PI
AMAG

Putnam Investments’s AMAG Pharmaceuticals AMAG Stock Holding History

Putnam Investments’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-17,768
Closed -$618K – 1306
2016
Q4 		$618K Sell
17,768
-169,565
-91% -$5.07M ﹤0.01% 1095
2016
Q3 		$4.59M Sell
187,333
-203,122
-52% -$5.08M 0.01% 593
2016
Q2 		$9.34M Sell
390,455
-1,580,136
-80% -$36.2M 0.02% 430
2016
Q1 		$46.1M Sell
1,970,591
-1,119,517
-36% -$26.6M 0.11% 180
2015
Q4 		$93.3M Sell
3,090,108
-716,609
-19% -$23.2M 0.21% 103
2015
Q3 		$151M Buy
3,806,717
+1,179,165
+45% +$73.2M 0.34% 62
2015
Q2 		$181M Buy
2,627,552
+1,391,135
+113% +$87.5M 0.36% 58
2015
Q1 		$67.6M Buy
1,236,417
+137,655
+13% +$6.56M 0.13% 166
2014
Q4 		$46.8M Buy
1,098,762
+154,350
+16% +$5.58M 0.1% 217
2014
Q3 		$30.1M Buy
944,412
+813,573
+622% +$17.3M 0.06% 262
2014
Q2 		$2.71M Buy
+130,839
New +$2.42M 0.01% 958

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Putnam Investments's AMAG Position: Q1 2017 in Review

Putnam Investments sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 17,768 shares — an estimated $618K sold.

Putnam Investments first reported a position in AMAG in Q2 2014 and held it in 11 quarters. The position peaked at $181M in Q2 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Putnam Investments reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Putnam Investments sold 17,768 AMAG Pharmaceuticals shares in Q1 2017, an estimated $618K.
  • Putnam Investments first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 11 quarters.
  • Putnam Investments's AMAG Pharmaceuticals position peaked at $181M in Q2 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Putnam Investments's 13F filing for Q1 2017, filed 15 May 2017.